Consideration of the efficacy of non-ionic vesicles in the targeted delivery of oral vaccines

Jitinder S Wilkhu, Sarah E McNeil, David E Anderson, Yvonne Perrie

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The fundamentals of this research were to exploit non-ionic surfactant technology for delivery and administration of vaccine antigens across the oral route and to gain a better understanding of vaccine trafficking. Using a newly developed method for manufacture of non-ionic surfactant vesicles (niosomes and bilosomes) lower process temperatures were adopted thus reducing antigen exposure to potentially damaging conditions. Vesicles prepared by this method offered high protection to enzymatic degradation, with only ∼10 % antigen loss measured when vesicles incorporating antigen were exposed to enzyme digestion. Interestingly, when formulated using this new production method, the addition of bile salt to the vesicles offered no advantage in terms of stability within simulated gastro-intestinal conditions. Considering their ability to deliver antigen to their target site, results demonstrated that incorporation of antigen within vesicles enhanced delivery and targeting of the antigen to the Peyer's Patch, again with niosomes and bilosomes offering similar efficiency. Delivery to both the Peyer's patches and mesentery lymphatics was shown to be dose dependent at lower concentrations, with saturation kinetics applying at higher concentrations. This demonstrates that in the formulation of vaccine delivery systems, the lipid/antigen dose ratio is not only a key factor in production cost, but is equally a key factor in the kinetics of delivery and targeting of a vaccine system.

LanguageEnglish
Pages233-45
Number of pages13
JournalDrug Delivery and Translational Research
Volume4
Issue number3
Early online date4 Sep 2013
DOIs
Publication statusPublished - 30 Jun 2014

Fingerprint

Vaccines
Antigens
Peyer's Patches
Surface-Active Agents
Liposomes
Mesentery
Bile Acids and Salts
Digestion
Technology
Lipids
Costs and Cost Analysis
Temperature
Enzymes
Research

Keywords

  • niosomes
  • non-ionic-vesicles
  • vaccine delivery
  • cholesterol
  • influenza
  • adjuvants

Cite this

Wilkhu, Jitinder S ; McNeil, Sarah E ; Anderson, David E ; Perrie, Yvonne. / Consideration of the efficacy of non-ionic vesicles in the targeted delivery of oral vaccines. In: Drug Delivery and Translational Research. 2014 ; Vol. 4, No. 3. pp. 233-45.
@article{d08bb52adaa54da5b3b9897bf3827a75,
title = "Consideration of the efficacy of non-ionic vesicles in the targeted delivery of oral vaccines",
abstract = "The fundamentals of this research were to exploit non-ionic surfactant technology for delivery and administration of vaccine antigens across the oral route and to gain a better understanding of vaccine trafficking. Using a newly developed method for manufacture of non-ionic surfactant vesicles (niosomes and bilosomes) lower process temperatures were adopted thus reducing antigen exposure to potentially damaging conditions. Vesicles prepared by this method offered high protection to enzymatic degradation, with only ∼10 {\%} antigen loss measured when vesicles incorporating antigen were exposed to enzyme digestion. Interestingly, when formulated using this new production method, the addition of bile salt to the vesicles offered no advantage in terms of stability within simulated gastro-intestinal conditions. Considering their ability to deliver antigen to their target site, results demonstrated that incorporation of antigen within vesicles enhanced delivery and targeting of the antigen to the Peyer's Patch, again with niosomes and bilosomes offering similar efficiency. Delivery to both the Peyer's patches and mesentery lymphatics was shown to be dose dependent at lower concentrations, with saturation kinetics applying at higher concentrations. This demonstrates that in the formulation of vaccine delivery systems, the lipid/antigen dose ratio is not only a key factor in production cost, but is equally a key factor in the kinetics of delivery and targeting of a vaccine system.",
keywords = "niosomes, non-ionic-vesicles, vaccine delivery, cholesterol, influenza, adjuvants",
author = "Wilkhu, {Jitinder S} and McNeil, {Sarah E} and Anderson, {David E} and Yvonne Perrie",
note = "The final publication is available at Springer via http://dx.doi.org/10.1007/s13346-013-0174-7",
year = "2014",
month = "6",
day = "30",
doi = "10.1007/s13346-013-0174-7",
language = "English",
volume = "4",
pages = "233--45",
journal = "Drug Delivery and Translational Research",
issn = "2190-393X",
number = "3",

}

Consideration of the efficacy of non-ionic vesicles in the targeted delivery of oral vaccines. / Wilkhu, Jitinder S; McNeil, Sarah E; Anderson, David E; Perrie, Yvonne.

In: Drug Delivery and Translational Research, Vol. 4, No. 3, 30.06.2014, p. 233-45.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Consideration of the efficacy of non-ionic vesicles in the targeted delivery of oral vaccines

AU - Wilkhu, Jitinder S

AU - McNeil, Sarah E

AU - Anderson, David E

AU - Perrie, Yvonne

N1 - The final publication is available at Springer via http://dx.doi.org/10.1007/s13346-013-0174-7

PY - 2014/6/30

Y1 - 2014/6/30

N2 - The fundamentals of this research were to exploit non-ionic surfactant technology for delivery and administration of vaccine antigens across the oral route and to gain a better understanding of vaccine trafficking. Using a newly developed method for manufacture of non-ionic surfactant vesicles (niosomes and bilosomes) lower process temperatures were adopted thus reducing antigen exposure to potentially damaging conditions. Vesicles prepared by this method offered high protection to enzymatic degradation, with only ∼10 % antigen loss measured when vesicles incorporating antigen were exposed to enzyme digestion. Interestingly, when formulated using this new production method, the addition of bile salt to the vesicles offered no advantage in terms of stability within simulated gastro-intestinal conditions. Considering their ability to deliver antigen to their target site, results demonstrated that incorporation of antigen within vesicles enhanced delivery and targeting of the antigen to the Peyer's Patch, again with niosomes and bilosomes offering similar efficiency. Delivery to both the Peyer's patches and mesentery lymphatics was shown to be dose dependent at lower concentrations, with saturation kinetics applying at higher concentrations. This demonstrates that in the formulation of vaccine delivery systems, the lipid/antigen dose ratio is not only a key factor in production cost, but is equally a key factor in the kinetics of delivery and targeting of a vaccine system.

AB - The fundamentals of this research were to exploit non-ionic surfactant technology for delivery and administration of vaccine antigens across the oral route and to gain a better understanding of vaccine trafficking. Using a newly developed method for manufacture of non-ionic surfactant vesicles (niosomes and bilosomes) lower process temperatures were adopted thus reducing antigen exposure to potentially damaging conditions. Vesicles prepared by this method offered high protection to enzymatic degradation, with only ∼10 % antigen loss measured when vesicles incorporating antigen were exposed to enzyme digestion. Interestingly, when formulated using this new production method, the addition of bile salt to the vesicles offered no advantage in terms of stability within simulated gastro-intestinal conditions. Considering their ability to deliver antigen to their target site, results demonstrated that incorporation of antigen within vesicles enhanced delivery and targeting of the antigen to the Peyer's Patch, again with niosomes and bilosomes offering similar efficiency. Delivery to both the Peyer's patches and mesentery lymphatics was shown to be dose dependent at lower concentrations, with saturation kinetics applying at higher concentrations. This demonstrates that in the formulation of vaccine delivery systems, the lipid/antigen dose ratio is not only a key factor in production cost, but is equally a key factor in the kinetics of delivery and targeting of a vaccine system.

KW - niosomes

KW - non-ionic-vesicles

KW - vaccine delivery

KW - cholesterol

KW - influenza

KW - adjuvants

U2 - 10.1007/s13346-013-0174-7

DO - 10.1007/s13346-013-0174-7

M3 - Article

VL - 4

SP - 233

EP - 245

JO - Drug Delivery and Translational Research

T2 - Drug Delivery and Translational Research

JF - Drug Delivery and Translational Research

SN - 2190-393X

IS - 3

ER -